Clinical Trials
2
Active:2
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)RESIST : Administration of MAP4343 in Antidepressant Non-Responders Patients Experiencing a Major Depressive Episode
- First Posted Date
- 2019-03-12
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Mapreg
- Target Recruit Count
- 110
- Registration Number
- NCT03870776
- Locations
- 🇫🇷
CHU Angers, Angers, France
🇫🇷CHU Besançon, Besançon, France
🇫🇷CHD Vendée, La Roche-sur-Yon, France
News
No news found